Xenios Nova lung Kits - HSA Registration DE0510239
Access comprehensive regulatory information for Xenios Nova lung Kits in the Singapore medical device market through Pure Global AI's free database. This CLASS D medical device is registered under HSA registration number DE0510239 and owned by Xenios AG. The device was registered on January 15, 2025.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
The Novalung kits are intended to be part of the Xenios system for prolonged (up to 29 days) respiratory/cardiopulmonary life support that provides assisted extracorporeal circulation and physiologic gas exchange (oxygenation and CO2 removal) of the blood.

